In a total of 845 HCC patients, the elevated expression of UBE2S was significantly associated with higher tumor grade, larger tumor volume, vascular invasion, higher serum AFP level, advanced TNM stage, recurrence, and poorer outcomes (Pan et al., 2018). This evidence concerns the gene UBE2S and hepatocellular carcinoma.